Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20942890 | 0.87 | KDM4E (0.30) | — | |
| SCHEMBL20942889 | 0.87 | KDM4E (0.30) | — | |
| SCHEMBL20942881 | 0.80 | — | — | |
| SCHEMBL20942861 | 0.75 | — | — | |
| SCHEMBL1073334 | 0.75 | NOS3 (0.32) | NOS3NOS1NOS2 | |
| SCHEMBL9609470 | 0.73 | ESR1 (0.33) | — | |
| SCHEMBL28860670 | 0.72 | ALDH1A1 (0.30) | — | |
| SCHEMBL3459311 | 0.72 | NOS3 (0.36) | NOS3NOS1NOS2TLR4 | |
| SCHEMBL8357280 | 0.70 | TLR4 (0.32) | NOS3NOS1NOS2TLR4 | |
| SCHEMBL12809512 | 0.70 | CRBN (0.30) | TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
| WO-2023122724-A1 | IMPROVED SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| CN-1988955-B | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO | 2010-09-29 | — | — | CN | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| CN-1988955-A | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO (JP) | 2007-06-27 | — | — | CN | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20060173221-A1 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | NOS3 747/4885NOS1 499/4885NOS2 533/4885 |
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | FDFT1, DLST, PCMT1 | NOS3 1963/4885NOS1 1605/4885NOS2 1354/4885 |
| US-20060173221-A1 | Method for producing oxygen-containing compound | GPX4, DUOX2, SCO2 | NOS3 254/4885NOS1 263/4885NOS2 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.